References
- Isojarvi J I, Rattya J, Myllyla V V, et al. Valproate, lamotrigine, and insulin-mediated risks in women with epilepsy. Annals of Neurology 1998; 43(4)446–451
- McAuley K A, Williams S M, Mann, et al. Diagnosing insulin resistance in the general population. Diabetes Care 2001; 24(3)460–464
References
- Cassidy F, Ahearn E, Murry E, Forest K, Carroll B J. Diagnostic depressive symptoms of the mixed bipolar episode. Psychological Medicine 2000; 30: 403–411
- Benazzi F. Bipolar II depressive mixed state: finding a useful definition. Comprehensive Psychiatry 2003; 44(1)21–27
References
- Boksa P. Brain Res Brain Res Rev 2004; 45: 1–17
- Lipska B K, Weinberger D R. Neuropsychopharmacology 2000; 23: 223–39
References
- Pozzi, et al. J Neurochem 2003; 451–459
References
- Dean B, Bymaster F P, Scarr E. Muscarinic receptors in schizophrenia. Curr. Mol. Med. 2003; 3: 419–426
- Raedler T J, Knable M B, Jones D W, Urbina R A, Gorey J G, Lee K S, Egan M F, Coppola R, Weinberger D R. In vivo determination of muscarinic acetylcholine receptor availability in schizophrenia. Am. J. Psychiatry 2003; 160: 118–127